07:53 AM EDT, 06/20/2024 (MT Newswires) -- Tempest Therapeutics ( TPST ) shares surged more than 45% Thursday premarket after the company said Wednesday it will report fresh data from a phase 1b/2 trial of a combination treatment candidate for hepatocellular carcinoma.

Molecular Partners ( MOLN ) shares rose 22%, adding to Tuesday's rise.

Denali Capital Acquisition ( DECA ) shares increased 19% after the company disclosed in a regulatory filing that it is seeking more time to complete an initial business combination.

Best (BEST) shares advanced nearly 15% after the company agreed to a go-private deal.

Schmid Group ( SHMD ) shares were up more than 11%, extending Tuesday's gains.

Price: 4.1400, Change: +1.29, Percent Change: +45.26